摘要
目的:了解某院调节血脂药的使用情况,为促进临床合理用药提供参考。方法:收集2010—2012年某院临床调节血脂药的用量及销售金额,计算其年增长率;以世界卫生组织推荐的限定日剂量(DDD)为基础计算该类药的用药频度(DDDs)、限定日费用(DDC),并进行统计、分析。结果:2010—2012年该院调节血脂药用量及销售金额逐年上升,他汀类药占主导地位,其中阿托伐他汀年均增幅最大。结论:2010—2012年该院调节血脂药的应用呈递增趋势,他汀类是临床调节血脂药的首选,符合我国高脂血症发病的增长趋势。
OBJECTIVE ： To investigate the utilization of lipid-regulating drugs in a hospital for clinical reference of promoting rational use of drugs. METHODS： The lipid-regulating drugs used in a hospital during 2010-2012 period were analyzed statistically with regard to consumption amount, consumption sum, annual incremental rate, DDDs, defined daily dose costs （DDC） using DDD method recommended by WHO. RESULTS： The consumption amount, consumption sum of lipid-regulating drugs increased year by year, with statins showing predominant position and atorvastatin showing the greatest increase. CONCLUSION： The utilization of lipid-regulating drugs in this hospital during 2010-2012 period showed an upward trend, and statins was the first choice of lipid-regulating drugs clinically, which was in conformity with the increasing trend of the morbidity of hypedipidemia.
出处
《中国医院用药评价与分析》
2013年第6期519-521,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
